Health Oct 14 WATCH: FDA advisory committee debates Johnson & Johnson COVID-19 booster shots The FDA’s Vaccines and Related Biological Products Advisory Committee is expected to hold a meeting on Friday to discuss the emergency authorization of booster doses of the Johnson & Johnson COVID-19 vaccine for people 18 and older.
Health Oct 14 FDA panel endorses lower-dose Moderna COVID shot for booster U.S. health advisors said Thursday that some Americans who received Moderna’s COVID-19 vaccine should get a half-dose booster to bolster protection against the virus.
Health Oct 14 WATCH: FDA advisory committee endorses Moderna COVID booster shot The panel of advisers to the Food and Drug Administration voted unanimously to recommend a booster shot for seniors, adults with other health problems, jobs or living situations that put them at increased risk for COVID-19.
Economy Oct 12 FDA authorizes first e-cigarette, cites benefit for smokers For the first time, U.S. health officials have authorized an electronic cigarette, saying the R.J. Reynolds vaping device can benefit adult smokers.
Health Oct 12 FDA now begins to look at approving Moderna and Johnson & Johnson boosters After the FDA advisers give their recommendation, the agency itself will make an official decision on whether to authorize boosters. Then next week, a panel convened by the CDC will offer more specifics on who should get them.
Health Oct 11 Merck asks FDA to authorize anti-COVID pill If cleared by the Food and Drug Administration — a decision that could come in a matter of weeks — it would be the first pill shown to treat COVID-19.
Health Oct 05 J&J seeks U.S. clearance for COVID-19 vaccine booster doses Johnson & Johnson asked the Food and Drug Administration on Tuesday to allow extra shots of its COVID-19 vaccine as the U.S. government moves toward expanding its booster campaign to millions more vaccinated Americans.
Health Oct 01 Merck says experimental pill cuts worst effects of COVID-19 Drugmaker Merck says its experimental COVID-19 pill reduced hospitalizations and deaths by half in people recently infected with the coronavirus.
Science Sep 30 U.S. stem cell clinics boomed while FDA paused crackdown The Food and Drug Administration gave clinics three years to show that their questionable treatments were safe and worked. But today none of the clinics have won FDA approval and there are more businesses than before selling the treatments for…
Health Sep 22 FDA backs Pfizer COVID-19 boosters for seniors, high-risk The FDA on Wednesday signed off on such shots as a way to shore up protection in those groups. This is not a done deal yet: The CDC has yet to weigh in on who it believes should get boosters…